Bath & Body Works maintains sales and EPS guidance

Published 11/03/2025, 12:42
Bath & Body Works maintains sales and EPS guidance

Bath & Body Works, Inc. (NYSE:BBWI), a leading retail store chain, has reaffirmed its financial guidance for the first quarter and full-year fiscal 2025. Today, the company’s executive team participated in the Bank of America Consumer & Retail Conference, where they confirmed the previously announced net sales growth projections of 1% to 3% for both the first quarter and the full year.

In terms of earnings, Bath & Body Works expects first quarter 2025 earnings per diluted share to range from $0.36 to $0.43. For the full fiscal year, the company anticipates earnings per diluted share to be between $3.25 and $3.60. This announcement was made in conjunction with a fireside chat at the conference, which was also webcasted for investors.

The reaffirmation of guidance comes as a signal of stability from the company amidst a retail environment that is constantly evolving. InvestingPro data shows the company maintains a "GOOD" overall financial health score, with RSI indicators suggesting the stock is currently in oversold territory. It’s important to note that the information provided in this disclosure is not intended for filing purposes under the Securities Act of 1934, nor is it to be incorporated into any registration statement or document under the Securities Act of 1933.

Investors and interested parties were able to access the audio webcast through the Investor Relations section of Bath & Body Works’ website. The company, formerly known as L Brands, Inc., operates under the SIC Retail-Retail Stores, NEC [5990] and is headquartered in Columbus (WA:CLC), Ohio.

This news is based on a press release statement and is intended to provide investors with the latest financial outlook for Bath & Body Works, reflecting the company’s performance expectations for the current fiscal year.

In other recent news, Bath & Body Works reported its fourth-quarter 2024 earnings, revealing an earnings per share (EPS) of $2.09, which exceeded analyst expectations of $2.04. Despite this earnings beat, the company’s net sales fell by 4% year-over-year, totaling $2.8 billion, which led to a decline in investor confidence. The company has forecasted modest sales growth for 2025, projecting an EPS between $3.25 and $3.60. Bath & Body Works also highlighted its strategic initiatives, including new product lines and store expansions, as part of its growth strategy. The company returned $577 million to investors through dividends and share repurchases in 2024. Analyst firms have not recently upgraded or downgraded the stock, but the market remains cautious due to competitive pressures and macroeconomic conditions. Bath & Body Works plans to focus on product innovation and international expansion to drive future growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.